Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems

por Becker, M, Nitsche, A, Neumann, C, Aumann, J, Junghahn, I, Fichtner, I
Publicado 2002

JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA)

por Ikezoe, T, Yang, Y, Taguchi, H, Koeffler, H P
Publicado 2004

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study

por Ohwada, S, Ikeya, T, Yokomori, T, Kusaba, T, Roppongi, T, Takahashi, T, Nakamura, S, Kakinuma, S, Iwazaki, S, Ishikawa, H, Kawate, S, Nakajima, T, Morishita, Y
Publicado 2004

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

por Tang, Z, Du, R, Jiang, S, Wu, C, Barkauskas, D S, Richey, J, Molter, J, Lam, M, Flask, C, Gerson, S, Dowlati, A, Liu, L, Lee, Z, Halmos, B, Wang, Y, Kern, J A, Ma, P C
Publicado 2008

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment

por Slade, M J, Payne, R, Riethdorf, S, Ward, B, Zaidi, S A A, Stebbing, J, Palmieri, C, Sinnett, H D, Kulinskaya, E, Pitfield, T, McCormack, R T, Pantel, K, Coombes, R C
Publicado 2009

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)

por Gollins, S W, Myint, S, Susnerwala, S, Haylock, B, Wise, M, Topham, C, Samuel, L, Swindell, R, Morris, J, Mason, L, Levine, E
Publicado 2009

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia

por Molica, S, Vitelli, G, Levato, D, Ricciotti, A, Digiesi, G
Publicado 2002

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

por Fizazi, K, Prow, D M, Do, K-A, Wang, X, Finn, L, Kim, J, Daliani, D, Papandreou, C N, Tu, S-M, Millikan, R E, Pagliaro, L C, Logothetis, C J, Amato, R J
Publicado 2002

Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study

por Pahernik, S, Harris, A G, Schmitt-Sody, M, Krasnici, S, Goetz, A E, Dellian, M, Messmer, K
Publicado 2002

EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours

por Kim, S, Lim, B, Kim, J
Publicado 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado 2010

hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

por Cocco, E, Hu, Z, Richter, C E, Bellone, S, Casagrande, F, Bellone, M, Todeschini, P, Krikun, G, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Buza, N, Pecorelli, S, Lockwood, C J, Santin, A D
Publicado 2010

Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy

por Guillevin, R, Menuel, C, Taillibert, S, Capelle, L, Costalat, R, Abud, L, Habas, C, De Marco, G, Hoang-Xuan, K, Chiras, J, Vallée, J-N
Publicado 2011

Src homology domain-containing phosphatase 2 suppresses cellular senescence in glioblastoma

por Sturla, L-M, Zinn, P O, Ng, K, Nitta, M, Kozono, D, Chen, C C, Kasper, E M
Publicado 2011

Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide

por Chang, J, Varghese, D S, Gillam, M C, Peyton, M, Modi, B, Schiltz, R L, Girard, L, Martinez, E D
Publicado 2012

Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry

por Silva, C L, Passos, M, Câmara, J S
Publicado 2011

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems

por Lamb, G W A, Aitchison, M, Ramsey, S, Housley, S L, McMillan, D C
Publicado 2012

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

por Rohrmann, S, Grote, V A, Becker, S, Rinaldi, S, Tjønneland, A, Roswall, N, Grønbæk, H, Overvad, K, Boutron-Ruault, M C, Clavel-Chapelon, F, Racine, A, Teucher, B, Boeing, H, Drogan, D, Dilis, V, Lagiou, P, Trichopoulou, A, Palli, D, Tagliabue, G, Tumino, R, Vineis, P, Mattiello, A, Rodríguez, L, Duell, E J, Molina-Montes, E, Dorronsoro, M, Huerta, J-M, Ardanaz, E, Jeurnink, S, Peeters, P H M, Lindkvist, B, Johansen, D, Sund, M, Ye, W, Khaw, K-T, Wareham, N J, Allen, N E, Crowe, F L, Fedirko, V, Jenab, M, Michaud, D S, Norat, T, Riboli, E, Bueno-de-Mesquita, H B, Kaaks, R
Publicado 2012

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

por Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Publicado 2012

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells

por Oliveras-Ferraros, C, Cufí, S, Queralt, B, Vazquez-Martin, A, Martin-Castillo, B, de Llorens, R, Bosch-Barrera, J, Brunet, J, Menendez, J A
Publicado 2012